Know Cancer

forgot password

Vitrification of Oocytes From Female Cancer Patients to Preserve Their Fertility Potential

14 Years
42 Years
Not Enrolling

Thank you

Trial Information

Vitrification of Oocytes From Female Cancer Patients to Preserve Their Fertility Potential

Inclusion Criteria:

- Patients must be 14-42 year old females with a cancer diagnosis.

- Clearance letter from treating oncologist.

- Approval by program oncologist or her designee.

- Informed consent has to be signed after consultation with the program physician.
Minors require consent of a parent or a legal guardian and assent from the

- Life expectancy (predicted by their malignancy) of 5 or more years.

- Cancer diagnosis should have an expected cure rate of 50% or more, based upon
clinico-pathologic features.

Exclusion Criteria:

- Patients whose oncologist and the program oncologist concur that immediate oncologic
care should be rendered, not allowing sufficient time for a course of gonadotropin
therapy and egg retrieval.

- FSH level >20 MIU/ml, indicating abnormal ovarian function.

- Patients with stage IV cancers (*age appropriate women with stage IV advanced
Hodgkin's Lymphoma will be considered, as there is a significant long term survival
rate with this advanced disease).

- Patients with incurable cancer diagnoses.

- Patients who are unable or unwilling to sign the informed consent.

- Women cannot have an embryo transfer beyond age 50.

Type of Study:


Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

successful pregnancy

Outcome Description:

the primary objective of this study is the establishment of a successful pregnancy, following a disease-free interval after treatment for her cancer; this interval will be patient-dependent and will undoubtedly vary between participants.

Outcome Time Frame:

nine months after transfer of embryo(s)

Safety Issue:


Principal Investigator

Avner Hershlag, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Center for Human Reproduction


United States: Institutional Review Board

Study ID:




Start Date:

October 2010

Completion Date:

March 2013

Related Keywords:

  • Fertility
  • fertility preservation
  • oocyte cryopreservation
  • vitrification
  • egg freezing
  • fertility preservation in female cancer patients



Center for Human ReproductionManhasset, New York  11030